Trifluoromethyl fluorocoxib A detects cyclooxygenase-2 expression in inflammatory tissues and human tumor xenografts

ACS Medicinal Chemistry Letters

Volumn 5, Issue 4, 2014, Pages 446-450

  Uddin, Md Jashim ^a   Crews, Brenda C ^a   Huda, Imran ^a   Ghebreselasie, Kebreab ^a   Daniel, Cristina K ^a   Marnett, Lawrence J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer; Cyclooxygenase 2 (COX 2); inflammation; optical imaging

Indexed keywords

CELECOXIB; CONTRAST MEDIUM; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FLUOROCOXIB A; INDOMETACIN; TRIFLUOROMETHYL FLUOROCOXIB A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

EID: 84898041767     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400485g     Document Type: Article

References (13)

1. Vane, J. R. Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-Like Drugs Nat. New Biol. 1971, 231, 232-235
2. Smith, W. L.; Garavito, R. M.; DeWitt, D. L. Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and -2 J. Biol. Chem. 1996, 271, 33157-33160
3. Li, G.; Yang, T.; Yan, J. Cyclooxygenase-2 Increased the Angiogenic and Metastatic Potential of Tumor Cells Biochem. Biophys. Res. Commun. 2002, 299, 886-890
4. Taketo, M. M. Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part II) J. Natl. Cancer Inst. 1998, 90, 1609-1620
5. Gupta, R. A.; DuBois, N. Cyclooxygenase-2 Inhibitor Therapy for the Prevention of Esophageal Adenocarcinoma in Barrett's Esophagus J. Natl. Cancer Inst. 2002, 94, 406-407
6. Maier, T. J.; Schilling, K.; Schmidt, R.; Geisslinger, G.; Grosch, S. Cyclooxygenase-2 (COX-2)-Dependent and -Independent Anticarcinogenic Effects of Celecoxib in Human Colon Carcinoma Cells Biochem. Pharmacol. 2004, 67, 1469-1474
7. Uddin, M. J.; Crews, B. C.; Blobaum, A. L.; Kingsley, P. J.; Gorden, D. L.; McIntyre, J. O.; Matrisian, L. M.; Subbaramaiah, K.; Dannenberg, A. J.; Piston, D. W.; Marnett, L. J. Selective Visualization of Cyclooxygenase-2 in Inflammation and Cancer by Targeted Fluorescent Imaging Agents Cancer Res. 2010, 70, 3618-3627
8. Blobaum, A. L.; Uddin, M. J.; Felts, A. S.; Crews, B. C.; Rouzer, C. A.; Marnett, L. J. The 2′-Trifluoromethyl Analog of Indomethacin is a Potent and Selective COX-2 Inhibitor ACS Med. Chem. Lett 2013, 4 (5) 486-490
9. Uddin, M. J.; Marnett, L. J. Synthesis of 5- and 6-Carboxy-X-rhodamines Org. Lett. 2008, 10, 4799-4801
10. Kalgutkar, A. S.; Crews, B. C.; Rowlinson, S. W.; Marnett, A. B.; Kozak, K. R.; Remmel, R. P.; Marnett, L. J. Biochemically Based Design of Cyclooxygenase-2 (COX-2) Inhibitors: Facile Conversion of Nonsteroidal Antiinflammatory Drugs to Potent and Highly Selective COX-2 Inhibitors Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 925-930
11. Kalgutkar, A. S.; Kozak, K. R.; Crews, B. C.; Hochgesang, G. P., Jr.; Marnett, L. J. Covalent Modification of Cyclooxygenase-2 (COX-2) by 2-Acetoxyphenyl Alkyl Sulfides, a New Class of Selective COX-2 Inactivators J. Med. Chem. 1998, 41, 4800-4818
12. Meglio, P. D.; Ianaro, A.; Ghosh, S. Amelioration of Acute Inflammation by Systemic Administration of a Cell-Permeable Peptide Inhibitor of NF-κB Activation Arthrit. Rheum. 2005, 52, 951-958
13. Rowlinson, S. W.; Crews, B. C.; Lanzo, C. A.; Marnett, L. J. The Binding of Arachidonic Acid in the Cyclooxygenase Active Site of Mouse Prostaglandin Endoperoxide Synthase-2 (COX-2). A Putative L-Shaped Binding Conformation Utilizing the Top Channel Region J. Biol. Chem. 1999, 274, 23305-23310